Article
Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jun 2022
Winckelmann Anni, Fahnøe Ulrik, Bajpai Priyanka Shukla, Dalegaard Magnus Illum, Lundh Andreas, Ryom Lene, Bukh Jens, Weis Nina
Abstract excerpt
BACKGROUND: Chronic hepatitis B virus (HBV) treatment consists of nucleos(t)ide analogues to suppress viral replication. The HBV inhibitor tenofovir has a high barrier to resistance, however, evidence of virus-escape is emerging. This study investigates HBV evolution in patients undergoing tenofovir treatment with the primary aim to assess the emergence of putative resistance mutations. METHODS: HBV DNA was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
